PathoQuest, a life sciences spin-out of the Pasteur Institute and the Ecole Nationale Vétérinaire d’Alfort (ENVA), has raised €3.8m ($5m) in series B private equity (PE) funding. Participants in the round were PE firms IDInvest Partners, Kurma Life Science Partners, and Aurinvest. The funding will be used to fuel Paris-based PathoQuest’s trials and technology development.…
PathoQuest diagnoses $5m
Jul 30, 2013 •
LEADERSHIP SOCIETYInforming, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
More featured content
Resistance is futile: seven superconductor companies that want to change the world
From healthcare to fusion to quantum computing to space, superconductors have the potential to revolutionise the world. And the technology is finally ready to commercialise.
UK universities urged to lower spinout stakes
A new report recommends stakes of less than 25% but fails to address the issue of access to early-stage capital.
Feb 7, 2024
Mar 14, 2024
Monterey, CA (USA)
Jun 26, 2024